. “The Leaning Tower of PISA: Fundamental Problems in Ignorance-Based Theories of State Autonomy” . Critical Review . 2007.
Journal Article
. “Whose Deaths Matter? Mortality Identity and Attention to Disease in the Mass Media” . Journal of Health Politics Policy and Law . 2006;31(4):729-772.
. “Reputation Gatekeeping and the Politics of Post-marketing Drug Regulation”. Virtual Mentor [American Medical Association] [Internet]. 2006;8:403-406. Website
. “A Modest Proposal for Financing Postmarketing Drug Safety Studies by Augmenting FDA User Fees” . Health Affairs – Web Exclusive . 2005;W5 (469).
. “The Political Logic of Regulatory Error” . Nature Reviews – Drug Discovery . 2005;4(10):819-823.
. “Protection without Capture: Product Approval by a Politically Responsive Learning Regulator”. American Political Science Review . 2004;98(4):613-631.
. “Gatekeeping and the FDA’s Role in Human Subjects Protection” . Virtual Mentor [American Medical Association] . 2004;6.
. “Political Learning from Rare Events: Poisson Inference Fiscal Constraints and the Lifetime of Bureaus” . Political Analysis. 2004;12(3):201-232.
. “Staff Resources Speed FDA Drug Review” . Journal of Health Policy Politics and Law. 2004;29(3):431-442.
. “Accelerating Approval Times for New Drugs in the U.S”. The Regulatory Affairs Journal – Pharma. 2004;15(6):411-417.
- ‹ previous
- 2 of 4
- next ›